Pending postmarket study commitments dropping
James G. Dickinson
April 01 2007
The FDA says 71% (899) of pending postmarketing study commitments promised by drug sponsors at the time of approval have ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.